Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
neostigmin 2,5 mg glycopyrronium 500 µg injektionsvæske, opløsning, ampul a 1 ml |
Is a |
Product containing neostigmine (medicinal product) |
false |
Inferred relationship |
Some |
|
|
neostigmin 2,5 mg glycopyrronium 500 µg injektionsvæske, opløsning, ampul a 1 ml |
Is a |
Product containing neostigmine in parenteral dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|
neostigmin 2,5 mg glycopyrronium 500 µg injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Neostigmine (substance) |
false |
Inferred relationship |
Some |
|
|
neostigmin 2,5 mg glycopyrronium 500 µg injektionsvæske, opløsning, ampul a 1 ml |
Is a |
neostigmin + glycopyrronium |
false |
Inferred relationship |
Some |
|
|
neostigmin 2,5 mg glycopyrronium 500 µg injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Glycopyrronium bromide |
false |
Inferred relationship |
Some |
|
|
neostigmin 2,5 mg glycopyrronium 500 µg injektionsvæske, opløsning, ampul a 1 ml |
Has manufactured dose form |
injektionsvæske |
false |
Inferred relationship |
Some |
|
|
neostigmin 2,5 mg glycopyrronium 500 µg injektionsvæske, opløsning, ampul a 1 ml |
Is a |
Product containing neostigmine in parenteral dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|
neostigmin 2,5 mg glycopyrronium 500 µg injektionsvæske, opløsning, ampul a 1 ml |
Is a |
glycopyrrolat til parenteral anvendelse |
false |
Inferred relationship |
Some |
|
|
neostigmin 2,5 mg glycopyrronium 500 µg injektionsvæske, opløsning, ampul a 1 ml |
Has manufactured dose form |
Solution for injection |
false |
Inferred relationship |
Some |
|
|
neostigmin 2,5 mg glycopyrronium 500 µg injektionsvæske, opløsning, ampul a 1 ml |
Is a |
Product containing glycopyrronium bromide and neostigmine bromide |
false |
Inferred relationship |
Some |
|
|
neostigmin 2,5 mg glycopyrronium 500 µg injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Neostigmine bromide (substance) |
false |
Inferred relationship |
Some |
|
|